Cargando…

DEC2 Serves as Potential Tumor Suppressor in Breast Carcinoma

BACKGROUND: Identification of new biomarkers can facilitate the development of effective therapeutic strategies in breast cancer (BC). Data from previous studies have revealed that differentiated embryonic chondrocyte gene (DEC) 1 and DEC2 might involve in the progression of various cancer types. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Wentong, Li, Qian, Wang, Min, Zheng, Mingjie, Xu, Huirong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569433/ https://www.ncbi.nlm.nih.gov/pubmed/33101542 http://dx.doi.org/10.1155/2020/6053154

Ejemplares similares

The Potential Roles of Dec1 and Dec2 in Periodontal Inflammation
por: Wang, Xingzhi, et al.
Publicado: (2021)

DEC1 and DEC2 Crosstalk between Circadian Rhythm and Tumor Progression
por: Sato, Fuyuki, et al.
Publicado: (2016)

MT1G serves as a tumor suppressor in hepatocellular carcinoma by interacting with p53
por: Wang, Yingchao, et al.
Publicado: (2019)

Latexin expression is downregulated in human gastric carcinomas and exhibits tumor suppressor potential
por: Li, Yong, et al.
Publicado: (2011)

miR-199b-5p serves as a tumor suppressor in renal cell carcinoma
por: Lai, Yulin, et al.
Publicado: (2018)

MicroRNA-601 serves as a potential tumor suppressor in hepatocellular carcinoma by directly targeting PIK3R3
por: Song, Yanan, et al.
Publicado: (2022)

miR-195 Serves as a Tumor Suppressor in the Progression of Liposarcoma by Targeting OSBP
por: Cao, Ye, et al.
Publicado: (2020)

LINC01589 serves as a potential tumor-suppressor and immune-related biomarker in endometrial cancer: A review
por: Chen, Ruixin, et al.
Publicado: (2023)

Characteristics of metastasis and survival between male and female breast cancer with different molecular subtypes: A population‐based observational study
por: Fang, Wentong, et al.
Publicado: (2021)

USP13 serves as a tumor suppressor via the PTEN/AKT pathway in oral squamous cell carcinoma
por: Qu, Zhi, et al.
Publicado: (2019)

Synaptopodin-2: a potential tumor suppressor
por: Zheng, Zequn, et al.
Publicado: (2023)

Tumor Suppressor PLK2 May Serve as a Biomarker in Triple-Negative Breast Cancer for Improved Response to PLK1 Therapeutics
por: Gao, Yang, et al.
Publicado: (2021)

Transmembrane Transporter Sema3D Serves as a Tumor Suppressor in Localized Clear Cell Renal Cell Carcinoma
por: Xie, Ruiyang, et al.
Publicado: (2022)

miR-101-3p Serves as a Tumor Suppressor for Renal Cell Carcinoma and Inhibits Its Invasion and Metastasis by Targeting EZH2
por: Dong, Yunze, et al.
Publicado: (2021)

A Novel Tumor Suppressor SPINK5 Serves as an Independent Prognostic Predictor for Patients with Head and Neck Squamous Cell Carcinoma
por: Lv, Zhongjing, et al.
Publicado: (2020)

An E3 Ubiquitin Ligase RNF139 Serves as a Tumor-Suppressor in Glioma
por: Chen, Xiaofeng, et al.
Publicado: (2021)

DEC VT220
Publicado: (1983)

Milestone Dec. 85
Publicado: (1985)

Milestone Dec 85
Publicado: (1985)

MicroRNA-589 serves as a tumor suppressor microRNA through directly targeting metastasis-associated protein 2 in breast cancer
por: Chu, Jun
Publicado: (2019)

General Bill of Mortality for London, from Dec. 1835, to Dec. 15, 1836
Publicado: (1837)

miR-642 serves as a tumor suppressor in hepatocellular carcinoma by regulating SEMA4C and p38 MAPK signaling pathway
por: Yu, Zaijun, et al.
Publicado: (2020)

Potential Tumor Suppressor NESG1 as an Unfavorable Prognosis Factor in Nasopharyngeal Carcinoma
por: Liu, Zhen, et al.
Publicado: (2011)

Inhibition of DEC2 is necessary for exiting cell dormancy in salivary adenoid cystic carcinoma
por: Yang, Xiao, et al.
Publicado: (2021)

RORα, a Potential Tumor Suppressor and Therapeutic Target of Breast Cancer
por: Du, Jun, et al.
Publicado: (2012)

Town-Council Proceedings.—Dec. 2, 1856
por: Alison, W. P.
Publicado: (1857)

Semaphorin 3F Serves as a Tumor Suppressor in Esophageal Squamous Cell Carcinoma and is Associated With Lymph Node Metastasis in Disease Progression
por: Xie, Zhen, et al.
Publicado: (2020)

Novel oncogenes and tumor suppressor genes in hepatocellular carcinoma
por: Wang, Fang, et al.
Publicado: (2021)

NY DEC Takes on Fracking
por: Schmidt, Charles W.
Publicado: (2011)

Milestone Dec. 85/5
Publicado: (1985)

Milestone Dec. 85/7
Publicado: (1985)

Milestone Dec. 85/6
por: de Metz-Noblat, N
Publicado: (1985)

Meeting of Dec. 19, 1881
Publicado: (1882)

Meeting of Dec. 21, 1874
Publicado: (1875)

Correlation between DEC1/DEC2 and epithelial-mesenchymal transition in human prostate cancer PC-3 cells
por: Liu, Qiang, et al.
Publicado: (2018)

CCL14 serves as a novel prognostic factor and tumor suppressor of HCC by modulating cell cycle and promoting apoptosis
por: Zhu, Mengxuan, et al.
Publicado: (2019)

T cell suppressors of antitumor immunity. The production of Ly-1-,2+ suppressors of delayed sensitivity precedes the production of suppressors of protective immunity [published erratum appears in J Exp Med 1986 Dec 1;164(6):2131]
Publicado: (1986)

Tropomyosin-1 acts as a potential tumor suppressor in human oral squamous cell carcinoma
por: Pan, Hao, et al.
Publicado: (2017)

Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic target
por: Xie, Ping, et al.
Publicado: (2017)

ARID2: A new tumor suppressor gene in hepatocellular carcinoma
por: Zhao, Hong, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_j1tmi5u06rq6pbccoa9h7t3d9b